Increased p53 staining in normal skin of posttransplant, immunocompromised patients and implications for carcinogenesis

American Journal of Dermatopathology

Volumn 21, Issue 5, 1999, Pages 442-445

  Hudson, Amy R ^a   Antley, Catherine M ^b   Kohler, Sabine ^c   Smoller, Bruce R ^a,d  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Carcinogenesis; p53; Transplant

Indexed keywords

PROTEIN P53;

ARTICLE; BONE MARROW TRANSPLANTATION; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; TUMOR SUPPRESSOR GENE;

BONE MARROW TRANSPLANTATION; CELL NUCLEUS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOHISTOCHEMISTRY; NEOPLASMS; NUCLEAR PROTEINS; SKIN; STAINING AND LABELING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032852860     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-199910000-00006     Document Type: Article

References (20)

1. Hollstein M, Sidransky D, Vogelstein B, Harris C. p53 mutations in human cancers. Science 1991;253:49-53.
2. Zambetti G, Levine A. A comparison of the biologic activities of wild type and mutant p53. FASEB J 1993;7:855.
3. Kastan M, Zhan Q, el-Deiry W, et al. A mammalian cell cycle checkpoint pathway. Cell 1992;71:587-97.
4. Brash D, Ziegler A, Jonason A, Simon J, Kunala S, Leffell D. Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J Invest Dermatol Symposium Proc 1996;1:136-42.
5. Gibson G, O'Grady A, Kay E, Leader M, Muphy G. p53 tumor suppressor gene protein expression in premalignant and malignant skin lesions of kidney transplant recipients. J Am Acad Dermatol 1997;36:924-31.
6. Levine A, Momand J, Finlay C. The p53 tumor suppressor gene. Nature 1991;351:453-6.
7. Socie G, Scieux C, Gluckman E, et al. Squamous cell carcinomas after allogeneic bone marrow transplantation for aplastic anemia: further evidence of a multistep process. Transplantation 1998;66 (5):667-70.
8. Kress S, Sutter C, Strickland PT, Mukhtar H, Schweizer J, Schwarz M. Carcinogen-specific mutational pattern in the p53 gene in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin. Cancer Res 1992;52(22):6400-3.
9. Rady P, Scinicariello F, Wagner RF Jr, Tyring SK. p53 mutations in basal cell carcinomas. Cancer Res 1992;52:3804-6.
10. Dumaz N, Drougard C, Sarasin A, Daya-Grosjean L. Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients. Proc Natl Acad Sci USA 1993;90:10529-33.
11. McGregor JM, Berkhout RJM, Rozycka M, et al. p53 mutations implicate sunlight in post-transplant skin cancer irrespective of human papillomavirus status. Oncogene 1997;15(14):1737-40.
12. Baas IO, Mulder JWR, Offerhaus JA, Vogelstein B, Hamilton SR. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994;172:5-12.
13. Iggo R, Gatter K, Bartek J, Lane DP, Harris A. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 1990;335:675-9.
14. Gannon JV, Greaves R, Iggo R, Lane DP. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J 1990;9:1595-602.
15. Hall PA, McKee PH, Menage HD, Dover R, Lane DP. High levels of p53 protein in UV irradiated normal human skin. Oncogene 1993;8:203-7.
16. Pelisson I, Soler C, Chardonnet Y, Euvrard S, Schmitt D. A possible role for human papillomaviruses and c-myc, c-Ha-ras, and p53 gene alterations in malignant cutaneous lesions from renal transplant recipients. Cancer Detect Prev 1996;20(1):20-30.
17. Lennard L, Thomas S, Harrington CI, Maddocks JL. Skin cancer in renal transplant recipients is associated with increased concentrations of 6-thioguanine nucleotide in red blood cells. Br J Dermatol 1985;113(6):723-9.
18. Swann PF, Waters TR, Moulton DC, Xu YZ, Zheng Q, Edwards M, Mace R. Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine. Science 1996;273(5278):1109-11.
19. Doll R, Kinlen L. Immunosurveillance and cancer: epidemiological evidence. Br Med J 1970;4(732):420-2.
20. Kelly GE, Meikle W, Sheil AG. Scheduled and unscheduled DNA synthesis in epidermal cells of hairless mice treated with immunosuppressive drugs and UVB-UVA irradiation. Br J Dermatol 1987;117(4):429-40.